OpiCalc Logo

OpiCalc

805 Clinical Tools

Logo
OpiCalc
7-Point Dermoscopy ChecklistABSI (Burn Severity)AGEP ScoreAJCC Melanoma StagingALDEN AlgorithmBWH SCC StagingBody Surface Area (BSA)Breslow & Clark MicrostagingCTCAE Skin ToxicityDLQIEASI ScoreGAGS (Acne)HiSCRIGAIHS4Lund-Browder ChartMSK Melanoma NomogramMelanoma Risk ScreeningPASI ScorePOEMParkland FormulaRegiSCAR DRESS ValidationRevised Baux ScoreSCORADSCORTENmPASI
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

MissionPrivacyTerms

Melanoma Risk Screening

Melanoma Risk Screening: Assessment of phenotypic and historical risk factors. High risk indicates a need for professional dermatological surveillance.
Guidelines & Evidence

Clinical Details

Section 1

When to Use

When to Use

Screening healthy individuals for their baseline risk of developing cutaneous melanoma.
Identifying patients who require closer dermatologic surveillance (e.g., total body skin exams every 6-12 months).
Section 2

Formula & Logic

Risk Factors

Personal history of melanoma or non-melanoma skin cancer.
Family history of melanoma (first-degree relatives).
Presence of atypical (dysplastic) nevi.
High total nevus count (>50 or >100 depending on the model).
Phenotype: Fair skin, light eyes, red/blond hair, propensity to burn, freckling.
History of severe, blistering sunburns.
Section 3

Pearls/Pitfalls

Clinical Pearls

Atypical nevus syndrome (FAMMM) drastically increases risk, often requiring baseline cutaneous photography (mole mapping).
Risk calculators are purely predictive tools; they cannot rule out melanoma.
Section 4

Next Steps

Management

High Risk: Regular dermatologist screening, dedicated sun protection education, and patient counseling on self-skin exams.
Low Risk: Routine primary care screening and general sun protection advice.
Section 5

Evidence Appraisal

Last Comprehensive Review: 2026

Related Dermatology Tools

Breslow & Clark Microstaging
BWH SCC Staging
CTCAE Skin Toxicity
DLQI
EASI Score
GAGS
HiSCR
IGA
IHS4
Lund-Browder Chart
Have feedback about this calculator?Let us know.